What is Scotiabank’s Estimate for Albemarle FY2026 Earnings?

Albemarle Corporation (NYSE:ALB) – Research analysts at Scotiabank upped their FY2026 earnings per share estimates for shares of Albemarle in a research note issued on Monday, November 10th. Scotiabank analyst B. Isaacson now forecasts that the specialty chemicals company will earn $1.92 per share for the year, up from their previous estimate of $1.24. Scotiabank currently has a “Sector Perform” rating and a $85.00 target price on the stock. The consensus estimate for Albemarle’s current full-year earnings is ($0.04) per share.

ALB has been the subject of several other research reports. Robert W. Baird lifted their price objective on shares of Albemarle from $68.00 to $81.00 and gave the stock an “underperform” rating in a research report on Friday, November 7th. HSBC increased their price objective on shares of Albemarle from $75.00 to $87.00 and gave the company a “hold” rating in a research report on Friday, November 7th. Rothschild Redb raised shares of Albemarle to a “strong-buy” rating in a report on Friday, October 24th. Citigroup upped their price target on shares of Albemarle from $95.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, November 7th. Finally, Evercore ISI raised their price objective on shares of Albemarle from $88.00 to $100.00 and gave the stock an “in-line” rating in a research report on Tuesday. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, sixteen have assigned a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, Albemarle has a consensus rating of “Hold” and an average price target of $99.38.

Albemarle Stock Up 0.5%

ALB stock opened at $115.11 on Thursday. The company has a current ratio of 2.31, a quick ratio of 1.47 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $13.55 billion, a PE ratio of -12.35 and a beta of 1.70. Albemarle has a 1-year low of $49.43 and a 1-year high of $119.28. The business’s 50 day simple moving average is $90.95 and its 200 day simple moving average is $76.04.

Albemarle (NYSE:ALB) last issued its earnings results on Wednesday, November 5th. The specialty chemicals company reported ($0.19) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.92) by $0.73. The business had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.27 billion. Albemarle had a negative net margin of 18.61% and a negative return on equity of 1.87%. The firm’s revenue for the quarter was down 3.5% on a year-over-year basis. During the same period in the previous year, the company earned ($1.55) earnings per share.

Albemarle Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Shareholders of record on Friday, December 12th will be issued a $0.405 dividend. The ex-dividend date of this dividend is Friday, December 12th. This represents a $1.62 dividend on an annualized basis and a yield of 1.4%. Albemarle’s payout ratio is currently -101.89%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Manning & Napier Advisors LLC bought a new stake in shares of Albemarle in the third quarter valued at approximately $138,723,000. ProShare Advisors LLC raised its holdings in Albemarle by 48.5% in the 2nd quarter. ProShare Advisors LLC now owns 2,870,110 shares of the specialty chemicals company’s stock valued at $179,870,000 after acquiring an additional 937,538 shares in the last quarter. AQR Capital Management LLC raised its holdings in Albemarle by 22,047.4% in the 2nd quarter. AQR Capital Management LLC now owns 713,812 shares of the specialty chemicals company’s stock valued at $44,613,000 after acquiring an additional 710,589 shares in the last quarter. FengHe Fund Management Pte. Ltd. bought a new stake in shares of Albemarle during the 2nd quarter valued at $32,903,000. Finally, Caisse de depot et placement du Quebec acquired a new stake in shares of Albemarle during the 3rd quarter worth $41,239,000. 92.87% of the stock is owned by institutional investors.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.